UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

Favourable virological and clinical outcomes at 1 year after liver transplantation in hepatitis C virus-positive patients who received direct-acting antivirals on the waiting list

Journal of hepatology, 2017, Vol.66 (1), p.S197-S197

2017

Volltextzugriff (PDF)

Impact of direct-acting anti-HCV treatments before liver transplant on virological and clinical outcomes of HCV patients at one year after surgery

Digestive and liver disease, 2017-02, Vol.49 (1), p.e25-e26

2017

Volltextzugriff (PDF)

All Oral Sofosbuvir-Based Antiviral Therapy in Liver Transplant Recipients Affected by Moderate-Severe Hepatitis C Recurrence: Predictors of Viral Response and Survival

Journal of hepatology, 2016, Vol.64 (2), p.S535-S535

2016

Volltextzugriff (PDF)

P0063 : Sofosbuvir plus ribavirin for the treatment of severe hcv recurrence after liver transplantation: Preliminary data from a single-centre experience

Journal of hepatology, 2015-04, Vol.62, p.S316-S316

2015

Volltextzugriff (PDF)

Safety and efficacy of sofosbuvir-based antiviral therapy immediately after liver transplantation: A matched case–control analysis

Digestive and liver disease, 2016-02, Vol.48, p.e32-e32

2016

Volltextzugriff (PDF)

Feasibility and efficacy of sofosbuvir-based antiviral therapy before liver transplantation to prevent HCV recurrence: A monocentric experience

Digestive and liver disease, 2016-02, Vol.48, p.e29-e29

2016

Volltextzugriff (PDF)

All oral sofosbuvir-based antiviral therapy in liver transplant recipients affected by moderate-severe hepatitis C recurrence: Predictors of viral response and survival

Digestive and liver disease, 2016-02, Vol.48, p.e33-e33

2016

Volltextzugriff (PDF)

Antiviral therapy with sofosbuvir plus ribavirin for the treatment of severe HCV recurrence after liver transplantation: preliminary data from a single-centre experience

Digestive and liver disease, 2015-02, Vol.47, p.e26-e26

2015

Volltextzugriff (PDF)

Impact of pre-transplant cardiac risk factor burden on post-transplant events in liver transplant recipients

Digestive and liver disease, 2024-02, Vol.56, p.S43

2024

Volltextzugriff (PDF)

Outcomes of Liver Transplantation from Hepatitis B Core Antibody–Positive Donors in Viral Cirrhosis Patients: The Prevailing Negative Effect of Recipient Hepatitis C Virus Infection

Transplantation proceedings, 2012-09, Vol.44 (7), p.1963-1965

2012

Volltextzugriff (PDF)

Outcomes of Liver Transplantation in Simultaneously Hepatitis B Surface Antigen and Hepatitis C Virus RNA Positive Recipients: The Deleterious Effect of Donor Hepatitis B Core Antibody Positivity

Transplantation proceedings, 2012-09, Vol.44 (7), p.1960-1962

2012

Volltextzugriff (PDF)

Medium-term outcome of liver recipients from COVID-19 donors

Digestive and liver disease, 2023-03, Vol.55, p.S27-S28

2023

Volltextzugriff (PDF)

HBV/HDV coinfection: A long-lasting indication for liver transplantation

Digestive and liver disease, 2023-03, Vol.55, p.S31-S31

2023

Volltextzugriff (PDF)

623 LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA BEYOND MILAN CRITERIA: POTENTIAL IMPACT OF UCSF CRITERIA IN PATIENT SELECTION

Journal of hepatology, 2011-03, Vol.54, p.S252-S252

2011

Volltextzugriff (PDF)

OC.06.8: PANCREATIC CYSTIC NEOPLASM PREVALENCE IN LIVER TRANSPLANTATION CANDIDATES AND POST-TRANSPLANTATION OUTCOME

Digestive and liver disease, 2024-04, Vol.56, p.S159-S159

2024

Volltextzugriff (PDF)

Detection of coronary artery disease in liver transplant recipients: does stress echocardiography still have a role?

Digestive and liver disease, 2024-02, Vol.56, p.S42

2024

Volltextzugriff (PDF)

Early post-liver transplant HCV eradication with sofosbuvir/velpatasvir/voxilaprevir in NS5A-inhibitor experienced patients

Digestive and liver disease, 2022-03, Vol.54, p.S20

2022

Volltextzugriff (PDF)

Impact of direct-acting antivirals in the management of post-liver transplant recipients compared with the interferon-era

Digestive and liver disease, 2020-02, Vol.52, p.e69-e69

2020

Volltextzugriff (PDF)

OC-20 Prophylaxis of hepatitis B after liver transplantation: report of an Italian survey in a cohort of 2260 patients

Digestive and liver disease, 2013-02, Vol.45, p.S7-S7

2013

Volltextzugriff (PDF)

Proctocolectomy for Ulcerative Colitis After Liver Transplantation for Primary Sclerosing Cholangitis

Transplantation proceedings, 2009-05, Vol.41 (4), p.1390-1392

2009

Volltextzugriff (PDF)

Non-invasive markers of fibrosis at 3 years of follow-up in liver transplant recipients with moderate/severe hepatitis C recurrence, successfully treated with DAAs

Digestive and liver disease, 2019-02, Vol.51, p.e51-e52

2019

Volltextzugriff (PDF)

Individualized HBIG withdrawal in an historical cohort of liver transplant recipients in Italy

Digestive and liver disease, 2023-03, Vol.55, p.S50-S50

2023

Volltextzugriff (PDF)

Preemptive direct-acting antiviral therapy in naive or NS5A-relapser liver transplant recipients: a single centre experience

Journal of hepatology, 2018-04, Vol.68, p.S371

2018

Volltextzugriff (PDF)

FRI-022 - Preemptive direct-acting antiviral therapy in naive or NS5A-relapser liver transplant recipients: a single centre experience

Journal of hepatology, 2018-04, Vol.68, p.S371-S371

2018

Volltextzugriff (PDF)

THU-457 - Favourable virological and clinical outcomes at 1 year after liver transplantation in hepatitis C virus-positive patients who received direct-acting antivirals on the waiting list

Journal of hepatology, 2017, Vol.66 (1), p.S197-S197

2017

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(38)

Sprache

Englisch
(34)
Italienisch
(4)

Erscheinungsjahr

n.n

Zeitschrift / Serie

Digestive And Liver Disease
(17)
Journal Of Hepatology
(11)
Minerva Chirurgica
(4)
Transplantation Proceedings
(3)
Digestive And Liver Disease/digestive And Liver Disease
(2)
Annals Of Oncology
(1)
Liver Transplantation
(1)
Transplant International
(1)

3 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Favourable virological and clinical outcomes at 1 year after liver transplantation in hepatitis C virus-positive patients who received direct-acting antivirals on the waiting list

Impact of direct-acting anti-HCV treatments before liver transplant on virological and clinical outcomes of HCV patients at one year after surgery

All Oral Sofosbuvir-Based Antiviral Therapy in Liver Transplant Recipients Affected by Moderate-Severe Hepatitis C Recurrence: Predictors of Viral Response and Survival

P0063 : Sofosbuvir plus ribavirin for the treatment of severe hcv recurrence after liver transplantation: Preliminary data from a single-centre experience

Safety and efficacy of sofosbuvir-based antiviral therapy immediately after liver transplantation: A matched case–control analysis

Feasibility and efficacy of sofosbuvir-based antiviral therapy before liver transplantation to prevent HCV recurrence: A monocentric experience

All oral sofosbuvir-based antiviral therapy in liver transplant recipients affected by moderate-severe hepatitis C recurrence: Predictors of viral response and survival

Antiviral therapy with sofosbuvir plus ribavirin for the treatment of severe HCV recurrence after liver transplantation: preliminary data from a single-centre experience

Impact of pre-transplant cardiac risk factor burden on post-transplant events in liver transplant recipients

Outcomes of Liver Transplantation from Hepatitis B Core Antibody–Positive Donors in Viral Cirrhosis Patients: The Prevailing Negative Effect of Recipient Hepatitis C Virus Infection

Outcomes of Liver Transplantation in Simultaneously Hepatitis B Surface Antigen and Hepatitis C Virus RNA Positive Recipients: The Deleterious Effect of Donor Hepatitis B Core Antibody Positivity

Medium-term outcome of liver recipients from COVID-19 donors

HBV/HDV coinfection: A long-lasting indication for liver transplantation

623 LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA BEYOND MILAN CRITERIA: POTENTIAL IMPACT OF UCSF CRITERIA IN PATIENT SELECTION

OC.06.8: PANCREATIC CYSTIC NEOPLASM PREVALENCE IN LIVER TRANSPLANTATION CANDIDATES AND POST-TRANSPLANTATION OUTCOME

Detection of coronary artery disease in liver transplant recipients: does stress echocardiography still have a role?

Early post-liver transplant HCV eradication with sofosbuvir/velpatasvir/voxilaprevir in NS5A-inhibitor experienced patients

Impact of direct-acting antivirals in the management of post-liver transplant recipients compared with the interferon-era

OC-20 Prophylaxis of hepatitis B after liver transplantation: report of an Italian survey in a cohort of 2260 patients

Proctocolectomy for Ulcerative Colitis After Liver Transplantation for Primary Sclerosing Cholangitis

Non-invasive markers of fibrosis at 3 years of follow-up in liver transplant recipients with moderate/severe hepatitis C recurrence, successfully treated with DAAs

Individualized HBIG withdrawal in an historical cohort of liver transplant recipients in Italy

Preemptive direct-acting antiviral therapy in naive or NS5A-relapser liver transplant recipients: a single centre experience

FRI-022 - Preemptive direct-acting antiviral therapy in naive or NS5A-relapser liver transplant recipients: a single centre experience

THU-457 - Favourable virological and clinical outcomes at 1 year after liver transplantation in hepatitis C virus-positive patients who received direct-acting antivirals on the waiting list

Suchergebnisse filtern